Protagonist Therapeutics Income Statement (2017-2025) | PTGX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 8.78M11.28M10.78M11.67M6.12M2.35M1.56M-0.24M-0.21M13.11M5.65M6.19M2.27M10.29M8.62M25.72M0.90M-0.02M50.00M254.95M4.17M4.67M165.00M28.32M5.55M4.71M
Operating items
Research & Development 11.17M11.72M15.37M17.73M12.14M14.25M12.44M19.36M17.29M15.91M18.77M20.26M15.99M19.49M24.25M26.43M36.96M38.37M36.32M34.61M25.40M29.88M27.42M33.18M30.66M28.90M33.73M33.52M35.97M34.90M35.89M37.04M40.00M
Selling, General & Administrative 2.59M3.07M3.64M3.18M3.36M3.52M3.76M3.86M4.01M4.11M4.58M4.18M4.89M4.99M5.96M6.71M7.26M7.26M10.52M7.69M6.90M6.63M8.61M9.17M7.66M8.05M14.91M9.44M10.16M8.95M11.74M10.55M11.13M
Operating Expenses 13.76M14.79M19.01M20.91M15.51M17.77M16.21M23.22M21.31M20.02M23.34M24.43M20.89M24.48M30.21M33.15M44.21M45.63M46.83M42.30M32.30M36.52M36.02M42.35M38.33M36.95M48.64M42.96M46.13M43.86M47.63M47.59M51.13M
Operating Income -4.98M-3.51M-8.23M-9.24M-9.39M-15.41M-14.65M-31.41M-17.17M-17.30M-19.70M-18.22M-7.77M-18.83M-24.02M-30.88M-33.93M-37.02M-21.11M-41.44M-32.30M-36.52M-36.02M-42.35M-38.33M23.05M206.31M-38.79M-41.45M126.78M-19.31M-42.04M-46.42M
EBIT -4.98M-3.51M-8.23M-9.24M-9.39M-15.41M-14.65M-31.41M-17.17M-17.30M-19.70M-18.22M-7.77M-18.83M-24.02M-30.88M-33.93M-37.02M-21.11M-41.44M-32.30M-36.52M-36.02M-42.35M-38.33M23.05M206.31M-38.79M-41.45M126.78M-19.31M-42.04M-46.42M
Non-operating items
Interest & Investment Income 0.15M0.47M0.57M0.58M0.65M0.77M0.73M0.64M0.76M0.68M0.53M0.21M0.09M0.08M0.10M0.10M0.12M0.12M0.17M0.48M1.16M2.25M2.49M3.91M4.25M4.24M4.38M7.40M7.68M6.85M7.57M7.41M7.05M
Other Non Operating Income -0.01M-0.00M-0.04M-0.11M0.14M-0.49M-0.58M-0.06M-0.08M-0.06M-0.01M0.01M-0.08M-0.09M0.07M-0.20M-0.02M-0.03M0.04M-0.02M0.10M0.14M0.03M0.08M0.04M0.03M
Non Operating Income -0.01M-0.00M-0.04M-0.11M0.14M-0.49M0.51M-0.06M-0.01M-0.08M-0.06M-0.01M0.01M-0.08M-0.09M0.07M-0.20M-0.02M-0.03M0.04M-0.02M0.10M0.14M0.03M0.08M0.04M0.03M
Net income details
EBT -4.83M-3.04M-7.66M-8.66M-8.73M-14.66M-13.92M-30.80M-16.51M-16.64M-19.90M-18.29M-7.76M-25.11M-24.00M-30.84M-33.80M-37.15M-20.94M-40.96M-31.15M-34.27M-33.73M-38.46M-34.10M27.34M210.67M-31.29M-33.63M133.66M-11.65M-34.60M-39.34M
Tax Provisions -0.80M0.18M-1.63M-0.10M0.85M0.20M1.13M3.33M-0.70M-0.42M1.99M0.20M
Profit After Tax -4.83M-3.05M-7.66M-8.66M-8.73M-13.87M-14.10M-29.17M-16.41M-17.50M-20.08M-19.42M-7.76M-18.89M-24.00M-30.84M-33.80M-36.91M-20.93M-41.04M-31.23M-34.19M-33.73M-38.46M-34.10M27.34M207.34M-30.62M-33.21M131.67M-11.65M-34.77M-39.34M
Income from Continuing Operations -4.83M-3.04M-7.66M-8.66M-8.73M-13.86M-14.10M-29.17M-16.41M-17.49M-20.10M-19.42M-7.76M-25.11M-24.00M-30.84M-33.80M-37.15M-20.94M-40.96M-31.15M-34.27M-33.73M-38.46M-34.10M27.34M207.34M-30.59M-33.21M131.67M-11.65M-34.80M-39.34M
Consolidated Net Income -4.83M-3.04M-7.66M-8.66M-8.73M-13.86M-14.10M-29.17M-16.41M-17.49M-20.10M-19.42M-7.76M-25.11M-24.00M-30.84M-33.80M-37.15M-20.94M-40.96M-31.15M-34.27M-33.73M-38.46M-34.10M27.34M207.34M-30.59M-33.21M131.67M-11.65M-34.80M-39.34M
Income towards Parent Company -4.83M-3.04M-7.66M-8.66M-8.73M-13.86M-14.10M-29.17M-16.41M-17.49M-20.10M-19.42M-7.76M-25.11M-24.00M-30.84M-33.80M-37.15M-20.94M-40.96M-31.15M-34.27M-33.73M-38.46M-34.10M27.34M207.34M-30.59M-33.21M131.67M-11.65M-34.80M-39.34M
Net Income towards Common Stockholders -4.83M-3.04M-7.66M-8.66M-8.73M-13.86M-14.10M-29.17M-16.41M-17.49M-20.10M-19.42M-7.76M-25.11M-24.00M-30.84M-33.80M-37.15M-20.94M-40.96M-31.15M-34.27M-33.73M-38.46M-34.10M27.34M207.34M-30.59M-33.21M131.67M-11.65M-34.80M-39.34M
Additional items
EPS (Basic) -0.29-0.15-0.36-0.41-0.38-0.57-0.58-1.18-0.61-0.63-0.72-0.59-0.21-0.47-0.54-0.69-0.70-0.77-0.43-0.84-0.64-0.70-0.67-0.68-0.580.523.41-0.50-0.542.13-0.19-0.55-0.62
EPS (Weighted Average and Diluted) -0.54-0.69-0.70-0.77-0.43-0.84-0.64-0.70-0.67-0.68-0.580.523.26-0.50-0.542.01-0.19-0.55-0.62
Shares Outstanding (Weighted Average) 16.79M16.86M16.90M20.48M21.10M21.20M21.22M24.19M23.35M23.40M26.28M27.21M27.29M27.43M36.81M38.26M43.81M43.95M47.55M47.73M48.41M48.66M49.08M49.20M51.28M57.25M57.53M57.68M58.27M58.65M58.90M59.60M61.38M61.98M62.21M
Shares Outstanding (Diluted Average) 44.22M44.86M47.99M46.32M48.75M49.05M49.11M50.57M56.78M59.18M56.76M63.60M63.91M64.61M65.08M62.96M63.51M63.77M
EBITDA -4.98M-3.51M-8.23M-9.24M-9.39M-15.41M-14.65M-31.41M-17.17M-17.30M-19.70M-18.22M-7.77M-18.83M-24.02M-30.88M-33.93M-37.02M-21.11M-41.44M-32.30M-36.52M-36.02M-42.35M-38.33M23.05M206.31M-38.79M-41.45M126.78M-19.31M-42.04M-46.42M
Interest Expenses 0.24M0.21M0.02M0.13M
Tax Rate 5.46%5.29%0.62%1.58%2.24%1.25%1.49%